Chapter/Section Purchase

1 Study Coverage
1.1 Microneedle Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Microneedle Flu Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Solid Microneedle
1.2.3 Hollow Microneedle
1.2.4 Coated Microneedle
1.2.5 Dissolving Microneedle
1.3 Market by Application
1.3.1 Global Microneedle Flu Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Influenza A
1.3.3 Influenza B
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Microneedle Flu Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Microneedle Flu Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Microneedle Flu Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Microneedle Flu Vaccine Sales by Region
2.4.1 Global Microneedle Flu Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Microneedle Flu Vaccine by Region (2023-2028)
2.5 Global Microneedle Flu Vaccine Revenue by Region
2.5.1 Global Microneedle Flu Vaccine Revenue by Region (2017-2022)
2.5.2 Global Microneedle Flu Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Microneedle Flu Vaccine Sales by Manufacturers
3.1.1 Global Top Microneedle Flu Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Microneedle Flu Vaccine in 2021
3.2 Global Microneedle Flu Vaccine Revenue by Manufacturers
3.2.1 Global Microneedle Flu Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Microneedle Flu Vaccine Revenue in 2021
3.3 Global Microneedle Flu Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Microneedle Flu Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Microneedle Flu Vaccine Sales by Type
4.1.1 Global Microneedle Flu Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Microneedle Flu Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Microneedle Flu Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Microneedle Flu Vaccine Revenue by Type
4.2.1 Global Microneedle Flu Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Microneedle Flu Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Microneedle Flu Vaccine Price by Type
4.3.1 Global Microneedle Flu Vaccine Price by Type (2017-2022)
4.3.2 Global Microneedle Flu Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Microneedle Flu Vaccine Sales by Application
5.1.1 Global Microneedle Flu Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Microneedle Flu Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Microneedle Flu Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Microneedle Flu Vaccine Revenue by Application
5.2.1 Global Microneedle Flu Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Microneedle Flu Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Microneedle Flu Vaccine Price by Application
5.3.1 Global Microneedle Flu Vaccine Price by Application (2017-2022)
5.3.2 Global Microneedle Flu Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Microneedle Flu Vaccine Market Size by Type
6.1.1 North America Microneedle Flu Vaccine Sales by Type (2017-2028)
6.1.2 North America Microneedle Flu Vaccine Revenue by Type (2017-2028)
6.2 North America Microneedle Flu Vaccine Market Size by Application
6.2.1 North America Microneedle Flu Vaccine Sales by Application (2017-2028)
6.2.2 North America Microneedle Flu Vaccine Revenue by Application (2017-2028)
6.3 North America Microneedle Flu Vaccine Market Size by Country
6.3.1 North America Microneedle Flu Vaccine Sales by Country (2017-2028)
6.3.2 North America Microneedle Flu Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Microneedle Flu Vaccine Market Size by Type
7.1.1 Europe Microneedle Flu Vaccine Sales by Type (2017-2028)
7.1.2 Europe Microneedle Flu Vaccine Revenue by Type (2017-2028)
7.2 Europe Microneedle Flu Vaccine Market Size by Application
7.2.1 Europe Microneedle Flu Vaccine Sales by Application (2017-2028)
7.2.2 Europe Microneedle Flu Vaccine Revenue by Application (2017-2028)
7.3 Europe Microneedle Flu Vaccine Market Size by Country
7.3.1 Europe Microneedle Flu Vaccine Sales by Country (2017-2028)
7.3.2 Europe Microneedle Flu Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Microneedle Flu Vaccine Market Size by Type
8.1.1 Asia Pacific Microneedle Flu Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Microneedle Flu Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Microneedle Flu Vaccine Market Size by Application
8.2.1 Asia Pacific Microneedle Flu Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Microneedle Flu Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Microneedle Flu Vaccine Market Size by Region
8.3.1 Asia Pacific Microneedle Flu Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Microneedle Flu Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Microneedle Flu Vaccine Market Size by Type
9.1.1 Latin America Microneedle Flu Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Microneedle Flu Vaccine Revenue by Type (2017-2028)
9.2 Latin America Microneedle Flu Vaccine Market Size by Application
9.2.1 Latin America Microneedle Flu Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Microneedle Flu Vaccine Revenue by Application (2017-2028)
9.3 Latin America Microneedle Flu Vaccine Market Size by Country
9.3.1 Latin America Microneedle Flu Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Microneedle Flu Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Microneedle Flu Vaccine Market Size by Type
10.1.1 Middle East and Africa Microneedle Flu Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Microneedle Flu Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Microneedle Flu Vaccine Market Size by Application
10.2.1 Middle East and Africa Microneedle Flu Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Microneedle Flu Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Microneedle Flu Vaccine Market Size by Country
10.3.1 Middle East and Africa Microneedle Flu Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Microneedle Flu Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GC Pharma
11.2.1 GC Pharma Corporation Information
11.2.2 GC Pharma Overview
11.2.3 GC Pharma Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GC Pharma Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GC Pharma Recent Developments
11.3 Debiotech
11.3.1 Debiotech Corporation Information
11.3.2 Debiotech Overview
11.3.3 Debiotech Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Debiotech Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Debiotech Recent Developments
11.4 NanoPass Technologies
11.4.1 NanoPass Technologies Corporation Information
11.4.2 NanoPass Technologies Overview
11.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 NanoPass Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 NanoPass Technologies Recent Developments
11.5 Corium International
11.5.1 Corium International Corporation Information
11.5.2 Corium International Overview
11.5.3 Corium International Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Corium International Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Corium International Recent Developments
11.6 Becton Dickinson and Company
11.6.1 Becton Dickinson and Company Corporation Information
11.6.2 Becton Dickinson and Company Overview
11.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Becton Dickinson and Company Recent Developments
11.7 FluGen
11.7.1 FluGen Corporation Information
11.7.2 FluGen Overview
11.7.3 FluGen Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 FluGen Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 FluGen Recent Developments
11.8 CosMED Pharmaceuticals
11.8.1 CosMED Pharmaceuticals Corporation Information
11.8.2 CosMED Pharmaceuticals Overview
11.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CosMED Pharmaceuticals Recent Developments
11.9 Microdermics and OraSure Technologies
11.9.1 Microdermics and OraSure Technologies Corporation Information
11.9.2 Microdermics and OraSure Technologies Overview
11.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Microdermics and OraSure Technologies Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Microneedle Flu Vaccine Industry Chain Analysis
12.2 Microneedle Flu Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Microneedle Flu Vaccine Production Mode & Process
12.4 Microneedle Flu Vaccine Sales and Marketing
12.4.1 Microneedle Flu Vaccine Sales Channels
12.4.2 Microneedle Flu Vaccine Distributors
12.5 Microneedle Flu Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Microneedle Flu Vaccine Industry Trends
13.2 Microneedle Flu Vaccine Market Drivers
13.3 Microneedle Flu Vaccine Market Challenges
13.4 Microneedle Flu Vaccine Market Restraints
14 Key Findings in The Global Microneedle Flu Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer